WallStreetZenWallStreetZen

Bellring Brands Outlook: Strong Buy Rating, Analysts Forecast 15.9% EPS Growth

By Don Francis, Editor
January 17, 2024 8:33 AM UTC
Bellring Brands Outlook: Strong Buy Rating, Analysts Forecast 15.9% EPS Growth

Barclays's Lauren Lieberman raised their price target on Bellring Brands (NYSE: BRBR) by 3.7% from $54 to $56 on 2024/01/16. The analyst maintained their Strong Buy rating on the stock.

Lieberman, a top-ranked analyst specializing in the Basic Materials and Consumer Defensive sectors, recently conducted a thorough analysis of various sectors, including Consumer Goods. In this sector, Lieberman advised investors to seek out companies with a "digestible valuation" and a clear path to growing volume ahead of the Q4 reporting season.

The analyst also expressed interest in the Food sector and highlighted the importance of volume recovery. Lieberman noted that volume recovery in this space has largely lagged expectations and will be a key factor to watch going forward. The analyst cautioned that monolithic, macro-driven moves in staples names are likely to have less impact now that interest rates are expected to be in a tighter and lower band compared to the past three months.

Furthermore, Lieberman mentioned that there is potential in more "idiosyncratic names" now that concerns surrounding GLP-1s have subsided. This suggests that the analyst sees opportunities in unique and individual companies within the sector.

In addition to the update on Bellring Brands, Lieberman made several changes to other names in their portfolio. For Colgate Palmolive Co, Lieberman raised the price target by 9.3% to $82 and maintained a Hold rating. Coty Inc saw an increase in the price target by 18.2% to $13, also with a Hold rating. Kimberly Clark Corp had its price target raised by 4.1% to $128, with a Hold rating. On the other hand, Lieberman lowered the price target on Mccormick & Co Inc by -4.1% to $71, while Molson Coors Beverage Co saw a decrease in the price target by -1.5% to $64. Both companies maintained a Hold rating.

Turning our attention back to Bellring Brands, it's worth noting that 100% of top-rated analysts currently rate the stock as a Strong Buy or Buy, with no analysts considering it a Hold. Furthermore, no analysts recommend or strongly recommend selling the stock.

Analysts' consensus forecast for Bellring Brands suggests that the company's upcoming year will deliver earnings per share (EPS) of $1.44. If this forecast proves accurate, it would represent a 15.9% increase in EPS on a year-over-year basis.

Looking at Bellring Brands' stock performance, it has shown significant growth since its last quarterly report on September 30, 2023. The stock price has surged by 30.9% during this period and has risen by an impressive 100.8% year-over-year. Notably, Bellring Brands has outperformed the S&P 500, which has seen a 19.4% increase.

Bellring Brands, Inc. is a nutrition product manufacturer and seller based in the United States. The company offers a range of products, including ready-to-drink protein shakes, other beverages, powders, nutrition bars, and supplements. Its popular brands include Premier Protein, Dymatize, PowerBar, Joint Juice, and Supreme Protein. Bellring Brands distributes its products through various channels, including club, e-commerce, convenience, specialty, and through brokers and distributors. Established in 2019, Bellring Brands operates as a subsidiary of Post Holdings, Inc.

Is BRBR a Buy, Hold or Sell?

WallStreetZen tracks the performance of nearly 4,000 Wall Street analysts, whom we rank by average returns, frequency, and win-rate (backtested over multiple years).

Create a free watchlist and be the first to know when top-rated Wall Street analysts revise their BRBR price target.

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen and Don Francis do not hold any positions in the companies mentioned in this article. The information and statistics provided herein are presented for general informational purposes only and may not be accurate, complete, or up-to-date. It should not be interpreted as a recommendation to buy or sell any stocks and should not be solely relied upon for making investment decisions. It does not take into account your financial situation or risk profile. All investors should conduct their own investment due diligence before buying a stock. WallStreetZen expressly disclaims any liability for the accuracy, reliability, or completeness of the analysts' information, price targets, ratings, or opinions.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.